BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 947029)

  • 1. Pharmacokinetic approach to the clinical use of lidocaine intravenously.
    Greenblatt DJ; Bolognini V; Koch-Weser J; Harmatz JS
    JAMA; 1976 Jul; 236(3):273-7. PubMed ID: 947029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on intravenous administration of lignocaine in patients with myocardial infarction.
    Campbell NP; Kelly JG; Adgey AA; McDevitt DG; Pantridge JF
    Br Heart J; 1978 Dec; 40(12):1371-5. PubMed ID: 737094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple method for maintaining serum lidocaine levels in the therapeutic range.
    Wong BY; Hurwitz A
    Arch Intern Med; 1985 Sep; 145(9):1588-91. PubMed ID: 4026487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy.
    Vaughan DP; Tucker GT
    Eur J Clin Pharmacol; 1976; 10(6):433-40. PubMed ID: 1001359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of methods of lidocaine administration in patients.
    Salzer LB; Weinrib AB; Marina RJ; Lima JJ
    Clin Pharmacol Ther; 1981 May; 29(5):617-24. PubMed ID: 7214792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of lidocaine by continuous infusion.
    Bassan MM; Weinstein SR; Mandel WJ
    Am Heart J; 1974 Mar; 87(3):302-3. PubMed ID: 4812367
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of perioperative lidocaine infusion and bis monitorization on remifentanil dosage in hypotensive anesthesia.
    Uzun S; Yuce Y; Erden A; Aypar U
    Eur Rev Med Pharmacol Sci; 2014; 18(4):559-65. PubMed ID: 24610623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood levels of lidocaine after various infusion rates in patients with acute myocardial infarction.
    Rydén L; Waldenström A; Winsnes Y; Ortengren B
    Am Heart J; 1975 Apr; 89(4):470-3. PubMed ID: 1114978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravenous mexiletine and lidocaine for the treatment of ventricular arrhythmias.
    Lui HK; Harris FJ; Chan MC; Lee G; Mason DT
    Am Heart J; 1986 Dec; 112(6):1153-8. PubMed ID: 3788761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for constant plasma drug concentrations: application to lidocaine.
    Riddell JG; McAllister CB; Wilkinson GR; Wood AJ; Roden DM
    Ann Intern Med; 1984 Jan; 100(1):25-8. PubMed ID: 6691655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidocaine therapy with an exponentially declining infusion. Clinical evaluation of an optimized dosing technique.
    Sebaldt RJ; Nattel S; Kreeft JH; Ogilvie RI
    Ann Intern Med; 1984 Nov; 101(5):632-4. PubMed ID: 6486594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic effects in dogs of lidocaine administered orally and intravenously.
    Smith ER; Duce BR; Boyes RN
    Am Heart J; 1972 Mar; 83(3):365-72. PubMed ID: 5059580
    [No Abstract]   [Full Text] [Related]  

  • 13. Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.
    Davison R; Parker M; Atkinson AJ
    Am Heart J; 1982 Aug; 104(2 Pt 1):203-8. PubMed ID: 7102503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the duration of infusion on the disposition of lidocaine in dogs.
    LeLorier J; Moisan R; Gagné J; Caillé G
    J Pharmacol Exp Ther; 1977 Dec; 203(3):507-11. PubMed ID: 925956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of lidocaine resistance in man using intermittent large-dose infusion techniques.
    Alderman EL; Kerber RE; Harrison DC
    Am J Cardiol; 1974 Sep; 34(3):342-9. PubMed ID: 4851926
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plasma level of lidocaine following intraoperative bolus injection and infusion in heart failure].
    Biscoping J; von Bormann B; Boldt J; Kling D; Hempelmann G
    Anasth Intensivther Notfallmed; 1984 Oct; 19(5):250-2. PubMed ID: 6335002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
    Fredrick DS; Boersma RB
    Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and central nervous system effects of co-administered lidocaine and bupivacaine in piglets.
    Kyttä J; Heavner JE; Badgwell JM; Rosenberg PH
    Reg Anesth; 1991; 16(2):89-94. PubMed ID: 2043532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion.
    Estes NA; Manolis AS; Greenblatt DJ; Garan H; Ruskin JN
    Am Heart J; 1989 May; 117(5):1060-4. PubMed ID: 2711965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved lidocaine infusion protocol for cardiac surgical patients.
    Landow L; Wilson J
    J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):209-13. PubMed ID: 1863739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.